CLINICAL_TRIALS
trial_result
· 2021-12-08
Clinical Trial Update: E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer [EARLY_Phase 1]
Summary
Early-phase trial evaluating E7 TCR T cell induction immunotherapy for stage IIB-IVA cervical cancer; trial terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Uterine Cervical Neoplasms | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2021-12-08